Lazanda Approved for Cancer Pain (HealthDay)
HealthDay – FRIDAY, July 1 (HealthDay News) — Lazanda (fentanyl) nasal spray has been approved by the U. S. Food and Drug Administration to treat breakthrough pain in adults with cancer who are already receiving opioid therapy, drug maker Archimedes Pharma said.
View full post on Yahoo! News: Health News
Leave a Reply